The IPO Buzz: Peru’s Healthcare Firm Auna (AUNA) Prices IPO at $12.00 – $1.00 Below Range

Auna S.A. (AUNA), a Latin American healthcare provider backed by Peru’s private equity firm Enfoca, priced its IPO at $12.00 – $1.00 below its $13.00-to-$15.00 range – on 30.0 million shares- the number of shares in the prospectus – to raise $360.0 million on Thursday night, March 21, 2024. Auna raised $60 million less than anticipated. The IPO was expected to raise $420 million, based on pricing at the $14.00 mid-point of its range. Auna’s stock is expected to start trading Friday, March 22, on the New York Stock Exchange.

Morgan Stanley, J.P. Morgan, BTG Pactual and Santander were the IPO’s global coordinators and joint book-runners. Citigroup and HSBC also were joint book-runners.

The IPO’s pricing marked a milestone for Auna. The Peruvian healthcare company had initially filed to go public in 2020. Auna withdrew those plans in 2022.

Auna, based in Lima, Peru, will use most of the IPO’s proceeds to repay debt related to acquisitions in 2022, the prospectus says.

Enfoca, a leading Peruvian private equity firm and Auna’s controlling shareholder, will own about 72.9 percent of the company’s Class B shares – or 68.3 percent of the combined voting power of Auna’s outstanding stock – after the IPO, the prospectus says.

A cornerstone investor, AFP Integra S.A., had indicated an interest in buying up to $100.0 million of Class A ordinary shares at the IPO price, the prospectus says.

Auna provides prepaid healthcare plans in Peru as well as dental and vision plans in Mexico, the prospectus says. The Peruvian company also runs hospitals and clinics “in Spanish-speaking Latin America – specifically, in Mexico, Colombia and Peru,” the prospectus says.

As of Dec. 31, 2023, Auna’s network of facilities included 15 hospitals with 2,301 beds and 16 outpatient, prevention and wellness facilities in Mexico, Peru, and Colombia, according to the prospectus.

Auna reported a net loss of $57.9 million on about $1.05 billion in revenue for the 12 months that ended Dec. 31, 2023, according to the prospectus.

(For more information about this company, please check the IPO Calendar and the individual IPO Profile found on our website: IPOScoop.com )

Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.

To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.

Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.

Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.